Glycobiology Market

研究執行與發布：Coherent Market Insights　·　發布日期 2026-02-19　·　152 頁
由量子訊息有限公司（Quantum Information）在台灣代理銷售與提供授權諮詢。

2026 年市場規模: USD 2.2 Bn
2033 年預估規模: USD 7.48 Bn
年複合成長率 CAGR: 19.1%

以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。

出版商 Coherent Market Insights 產業別 Healthcare & Life Sciences出版日期 2026-02-19頁數 152報告編號 CMI3639

授權報價

Single User Price	$4,500 USD
Enterprise License	$10,000 USD

洽詢購買申請 Sample

完整報告名稱與涵蓋範圍

Glycobiology Market, By Product Type (Instruments, Enzymes (Glycosidase (Heparinase, Chitinase, Acetylgalactosaminidase, PNGase, Chitobiase, Others (Hyaluronidase , Hexosaminidase)), GlcNAc Transferases (Acetylglucosaminyltransferase, Exostosin, Other (Glucosaminyl Transferase, Glucuronyltransferase)), GalNAc Transferases (Polypeptide GalNAc Transferase, GANLTL, Others (GD2 Synthase,B3GANLT)), Fucosyl Transferases, Galactosyl Transferases, Carbohydrate Kinases, Others ( Pentosyl Transferase, Nuraminidases)), Consumables, Reagent & kits), By Application (Diagnostic Application, Industrial Application, Therapeutic Application, Drug Discovery and Development, Others), By End User (Research Laboratories, Hospitals, Diagnostic Centers, Biopharmaceutical Companies, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

報告摘要

Glycobiology is the branch of science which deals with the study of Glycan and glycan-modified biomolecules such as glycolipids, glycoproteins and glycosylated small molecules collectively referred to as sugar molecules. Glycan are universal in all aspects of life. The binding of carbohydrate structures to biomolecules, including lipids, proteins, metabolites, and nucleic acids, can profoundly affect their physicochemical properties, subcellular localization, immunogenicity, and pharmacokinetics and pharmacodynamics. All cells and many proteins such as glycoproteins are covered with dense and complex arrays of covalently linked sugar chains (called oligosaccharides or glycan). The biological roles of these glycan are of particular importance in the assembly of complex multicellular organs and organisms, processes that require interactions between cells and with the surrounding extracellular matrix. Most classes of glycan are found on the surface of cells and secreted macromolecules. In addition, simple, rapidly metabolizing protein-bound glycan are abundant in the nucleus and cytoplasm, where they function as regulatory switches. Glycan are diverse and complex molecules whose functions are determined by their unique structures. Glycan structures requires effective enzymatic tools and analytical techniques and can be associated with specific functions. Glycosylation defines the adhesive properties of proteins and cells. The immune system functions primarily through carbohydrate-protein interactions, highlighting the importance of carbohydrates in physiology, pathogen recognition, cancer, and autoimmune diseases. Market Dynamics Major factors driving growth of the glycobiology market include adoption of inorganic growth strategies such as acquisitions by key players in the market. For instance, in June, 2018, Agilent Technologies, an American life science company, has acquired privately held ProZyme Inc., a provider of glycan analysis, reagents and kits. This acquisition will help the company expand its glycobiology product portfolio Key features of the study • This report provides in-depth analysis of the global glycobiology market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players • It profiles key players in the global glycobiology market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies • Key companies covered as a part of this study include Tracxn Technologies Limited, Agilent Tecnologies,Inc., Blirt.eu, Takara Bio Inc., Bio-Techne, Bruker Corporation, Thermo Fisher Scientific Inc., Shimadzu Corporation, New England Biolabs., Waters.co., Merck KGaA, Palleon Pharmaceuticals, Asparia Glycomics, RayBiotech Life, Inc., Z Biotech, LLC., Chemily Glycoscience, Lectenz Bio, 2BScientific , and Glycodiag • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics • The global glycobiology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global glycobiology market Market Segmentation • Product Type Insights (Revenue, USD Bn, 2026 - 2033) o Instruments o Enzymes  Glycosidase o Heparinase o Chitinase o Acetylgalactosaminidase o PNGase o Chitobiase o Others (Hyaluronidase , Hexosaminidase)  GlcNAc Transferases o Acetylglucosaminyltransferase o Exostosin o Others (GD2 Synthase,B3GANLT)  GalNAc Transferases o Polypeptide GalNAc Transferase o GANLTL o Others  Fucosyl Transferases  Galactosyl Transferases  Carbohydrate Kinases  Others o Consumables o Reagents & Kits • Application Insights (Revenue, USD Bn, 2026 - 2033) o Diagnostic Application o Industrial Application o Therapeutic Application o Drug Discovery and Development o Others • End User Insights (Revenue, USD Bn, 2026 - 2033) o Research Laboratories o Hospitals o Diagnostic Centres o Biopharmaceutical Companies o Others o Food • Regional Insights (Revenue, USD Bn, 2026 - 2033) o North America  U.S.  Canada o Latin America  Brazil  Argentina  Mexico  Rest of Latin America o Europe  Germany  U.K.  France  Italy  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific o Middle East  GCC  Israel  Rest of Middle East o Africa  North Africa  Central Africa  South Africa • Key Players Insights o Tracxn Technologies Limited o Agilent Tecnologies, Inc o Blirt.eu o Takara Bio Inc. o Bio-Techne o Bruker Corporation o Thermo Fisher Scientific Inc o Shimadzu Corporation o New England Biolabs. o Waters.co. o Merck KGaA o Palleon Pharmaceuticals o Asparia Glycomics o RayBiotech Life, Inc o Z Biotech, LLC o Chemily Glycoscience o Lectenz Bio, o 2BScientific o Glycodiag

目錄 Table of Contents

Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Overview o Report Description  Market Definition and Scope o Executive Summary  Global Glycobiology Market, By Product Type  Global Glycobiology Market, By Application  Global Glycobiology Market, By End User  Global Glycobiology Market, By Region 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics o Impact Analysis o Key Highlights o Regulatory Scenario o Product Launches/Approvals o PEST Analysis o PORTER’s Analysis o Market Opportunities o Regulatory Scenario o Key Developments o Industry Trend 4. Global Glycobiology Market, By Product Type, 2020-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2021 - 2033  Segment Trends o Instruments  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn) o Enzymes  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)  Segment Trends o Glycosidase  Heparinase  Chitinase  Acetylgalactosaminidase  PNGase  Chitobiase  Others o GlcNAc Transferases  Acetylglucosaminyltransferase  Exostosin  Others o GalNAc Transferases  Polypeptide GalNAc Transferase  GANLTL  Others o Fucosyl Transferases o Galactosyl Transferases o Carbohydrate Kinases o Others o Consumables  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn) o Reagents & Kits  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn) 5. Global Glycobiology Market, By Application, 2020-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2021 - 2033  Segment Trends o Diagnostic Application  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn) o Industrial Application  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn) o Therapeutic Application  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn) o Drug Discovery and Development  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn) 6. Global Glycobiology Market, By End User, 2020-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2021 - 2033  Segment Trends o Research Laboratories  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn) o Hospitals  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn) o Diagnostic Centres  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn) o Biopharmaceutical Companies  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn) o Food  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn) 7. Global Glycobiology Market, By Region, 2020 - 2033, Value (USD Bn) o Introduction  Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)  Market Y-o-Y Growth Analysis (%), 2021 - 2033, Value (USD Bn)  Regional Trends o North America  Introduction  Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Bn)  Market Size and Forecast, By Application, 2020 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2020 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn) o U.S. o Canada o Latin America  Introduction  Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Bn)  Market Size and Forecast, By Application, 2020 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2020 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn) o Brazil o Argentina o Mexico o Rest of Latin America o Europe  Introduction  Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Bn)  Market Size and Forecast, By Application, 2020 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2020 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn) o Germany o U.K. o Spain o France o Italy o Russia o Rest of Europe o Asia Pacific  Introduction  Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Bn)  Market Size and Forecast, By Application, 2020 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2020 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn) o China o India o Japan o Australia o South Korea o ASEAN o Rest of Asia Pacific o Middle East  Introduction  Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Bn)  Market Size and Forecast, By Application, 2020 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2020 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn) o GCC Countries o Israel o Rest of Middle East o Africa  Introduction  Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Bn)  Market Size and Forecast, By Application, 2020 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2020 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn) o South Africa o North Africa o Central Africa 8. Competitive Landscape o Tracxn Technologies Limited  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Agilent Tecnologies, Inc  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Blirt.eu  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Takara Bio Inc.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Bio-Techne  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Bruker Corporation  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Thermo Fisher Scientific Inc  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Shimadzu Corporation  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o New England Biolabs.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Waters.co.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Merck KGaA  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Palleon Pharmaceuticals  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Asparia Glycomics  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o RayBiotech Life, Inc  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Z Biotech, LLC  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Chemily Glycoscience  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Lectenz Bio,  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o 2BScientific  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Glycodiag  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies 9. Analyst Recommendations o Wheel of Fortune o Analyst View o Coherent Opportunity Map 10. References and Research Methodology o References o Research Methodology o About us

提及公司

Tracxn Technologies LimitedAgilent Tecnologies, IncBlirt.euTakara Bio Inc.Bio-TechneBruker CorporationThermo Fisher Scientific IncShimadzu CorporationNew England Biolabs.Waters.co.Merck KGaAPalleon PharmaceuticalsAsparia GlycomicsRayBiotech Life, IncZ Biotech, LLCChemily GlycoscienceLectenz Bio,2BScientificGlycodiag

同分類最新報告（醫療與生命科學）

常見問題

這份報告可以先索取樣本嗎？

可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算？

報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付？如何付款？

一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・聯絡我們